Patterns and Predictors of Oral Anticancer Agent Use in Diverse Patients With Metastatic Renal Cell Carcinoma.
Stephanie B WheelerLisa P SpeesBradford E JacksonChristopher D BaggettLauren E WilsonMelissa A GreinerDeborah R KayeTian ZhangDaniel J GeorgeCharles D ScalesJessica E PritchardMichaela A DinanPublished in: JCO oncology practice (2021)
These findings suggest a need to better understand the system-level and provider-level drivers of OAA underuse, as well as OAA adherence and associated survival.